PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 2043894

Depressive illness: diagnostic issues.

R M Hirschfeld
View original source ↗Export metadata ↓

Abstract

Mental health professionals have made significant advances in the understanding of depression, yet controversies continue about the classification of subtypes. After reviewing the history of approaches to the diagnosis of depression, the author summarizes current knowledge of the clinical course of the illness and the relevance of this knowledge to diagnosis. He concludes with a discussion of the renewed interest in depressive personality disorder and its relationship to the official nomenclature, as well as to related disorders.

Explore related subjects

Depressive DisorderHumansMood DisordersPersonality DisordersJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R M Hirschfeld. 1991. Depressive illness: diagnostic issues.. https://pubmed.ncbi.nlm.nih.gov/2043894/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Psychological morbidity and female urinary incontinence.

Female urinary incontinence is a common yet distressing condition. It affects women of all ages, but is especially common in the elderly. Its prevalence ranges from 15 to 55%, depending on age and population studied. Despite the ubiquity of female urinary incontinence, many incontinent women do not voice their suffering, and urinary incontinence has therefore been dubbed 'the silent epidemic'. The physical impact and social isolation associated with urinary incontinence lead to impairment of quality of life and psychological well-being. It is the aim of this review to discuss the epidemiology and psychological impact of urinary incontinence. The recognition and management of incontinence-related psychological morbidity are also explored.

Depressive Disorder↗
PubMed2007

Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings.

Vagus nerve stimulation (VNS) therapy is an effective adjunctive treatment for chronic or recurrent treatment-resistant depression in adults, and for pharmacoresistant epilepsy in adults and adolescents. VNS therapy is administered through an implanted pulse generator that delivers programmed electrical pulses through an implanted lead to the left vagus nerve. Programmable pulse parameters include output current, frequency, pulse width, and ON/OFF times. Within a range of typical values, individual patients respond best to different combinations of parameter settings. The physician must identify the optimum settings for each patient while balancing the goals of maximizing efficacy, minimizing side effects, and preserving battery life. Output current is gradually increased from 0.25 mA to the maximum tolerable level (maximum, 3.5 mA); typical therapeutic settings range from 1.0 to 1.5 mA. Greater output current is associated with increased side effects, including voice alteration, cough, a feeling of throat tightening, and dyspnea. Frequency is typically programmed at 20 Hz in depression and 30 Hz in epilepsy. Pulse width is typically 250 or 500 micros. The recommended initial ON time is 30 s, followed by 5 min OFF; OFF time > ON time is recommended. As with pharmacotherapy, VNS therapy must be adjusted in a gradual, systematic fashion to individualize therapy for each patient.

Depressive Disorder↗